These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 10766166)

  • 1. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
    Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
    Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
    Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C
    Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
    Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG
    Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
    Tussié-Luna MI; Rozo L; Roy AL
    Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.
    Meani N; Minardi S; Licciulli S; Gelmetti V; Coco FL; Nervi C; Pelicci PG; Müller H; Alcalay M
    Oncogene; 2005 May; 24(20):3358-68. PubMed ID: 15735696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
    He LZ; Merghoub T; Pandolfi PP
    Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
    Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of translocation t(15;17) on the gene expression regulation of myeloblastin during all trans retinoic acid induced myeloid differentiation in human leukemic cells].
    Ballerini P; Besançon F; Cayre YE
    C R Seances Soc Biol Fil; 1995; 189(4):521-30. PubMed ID: 8564566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
    Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia.
    Kitamura K; Kiyoi H; Yoshida H; Saito H; Ohno R; Naoe T
    Leukemia; 1997 Nov; 11(11):1950-6. PubMed ID: 9369431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells.
    Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E
    Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
    Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
    Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
    Nervi C; Ferrara FF; Fanelli M; Rippo MR; Tomassini B; Ferrucci PF; Ruthardt M; Gelmetti V; Gambacorti-Passerini C; Diverio D; Grignani F; Pelicci PG; Testi R
    Blood; 1998 Oct; 92(7):2244-51. PubMed ID: 9746761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
    Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
    Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.
    Zhu J; Lallemand-Breitenbach V; de Thé H
    Oncogene; 2001 Oct; 20(49):7257-65. PubMed ID: 11704854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.